These tests can show how well the kidneys are working and help prevent problems before they become serious
788 Other compounds, such as (+)-Epicatechin, 789 A0001, 790 and Nomlacofusp, 791 have also shown potential in treating Friedreichs ataxia, though further research is necessary
The medication is approved for adults with a body mass index (BMI) of 30 or higher or those with a BMI of 27 or higher and at least one weight-related medical condition
For someone with significant insulin resistance, the same workaround could backfire
Other peptides under investigation Several additional peptides are being studied for disc-related applications, though with less established evidence: Vasoactive Intestinal Peptide (VIP) has demonstrated the ability to slow disc degeneration progression and improve aggrecan levels in mouse studies
doi:10.1136/bmjopen-2013-002764